According to market research study published by Gen Consulting Company, the market size of the dry eye industry in UK is expected to rise by USD 48 million with a CAGR of 4.2% by the end of 2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into dry eye market in UK. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the dry eye industry.
This industry report offers market estimates and forecasts of the UK market, followed by a detailed analysis of the drug form, product, and distribution channel. The UK market for dry eye can be segmented by drug form: eye ointment, gel, liquid drops, others. Dry eye market is further segmented by product: anti-inflammatory drugs, artificial lubricant eye drops, autologous serum eye drops. Based on distribution channel, the dry eye market is segmented into: hospitals, online pharmacies, pharmacies & drug stores, others.
By drug form:
– eye ointment
– gel
– liquid drops
– others
By product:
– anti-inflammatory drugs
– artificial lubricant eye drops
– autologous serum eye drops
By distribution channel:
– hospitals
– online pharmacies
– pharmacies & drug stores
– others
The dry eye in UK market report offers detailed information on several market vendors, including Allergan plc (AbbVie Inc.), Bausch & Lomb Incorporated, I-MED Pharma, Inc., Johnson & Johnson, LGL Ltd., Novartis AG, Otsuka Pharmaceutical Co., Ltd. (OPC), Santen Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., Vision Direct Group Limited, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the dry eye market in UK.
– To classify and forecast the dry eye market in UK based on drug form, product, distribution channel.
– To identify drivers and challenges for the dry eye market in UK.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the dry eye market in UK.
– To identify and analyze the profile of leading players operating in the dry eye market in UK.
Why Choose This Report
– Gain a reliable outlook of the dry eye market in UK forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 4.2% |
| Pages | 86 |
| Key Players | Allergan plc (AbbVie Inc.), Bausch & Lomb Incorporated, I-MED Pharma Inc., Johnson & Johnson, LGL Ltd., Novartis AG, Otsuka Pharmaceutical Co. Ltd. (OPC), Santen Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Vision Direct Group Limited |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
